Zydus files US IND for lipid lowerer
This article was originally published in Scrip
Executive Summary
Zydus Cadila has filed an IND application with the US FDA for a lipid-lowering molecule. The molecule (ZYT1) is an anti-dyslipidaemic which may provide an alternative to statins or be added on to statin therapy.